ARTICLE | Company News
Isis other research news
February 14, 1994 8:00 AM UTC
ISIP (Carlsbad, Calif.) received a $500,000 Phase II SBIR grant from the National Institute of Allergy and Infectious Diseases to further development of antisense technologies targeting the 5' cap str...